August 30, 2014 2:41 AM ET

Biotechnology

Company Overview of OrthoCyte Corporation

Company Overview

OrthoCyte Corporation develops novel therapeutics based on stem cell technology for the treatment of injuries and disorders affecting the musculoskeletal system, including therapeutics that would regenerate bone, cartilage, tendons and ligaments. The company was founded in 2010 and is based in Alameda, California. OrthoCyte Corporation operates as a subsidiary of BioTime, Inc.

1301 Harbor Bay Parkway

Alameda, CA 94502

United States

Founded in 2010

Key Executives for OrthoCyte Corporation

Chief Executive Officer of Biotime
Age: 61
Vice President of Research and Business Development
Chief Scientific Officer
Age: 72
Compensation as of Fiscal Year 2014.

OrthoCyte Corporation Key Developments

OrthoCyte Corporation Presents at 2013 Stem Cell Meeting on the Mesa, Oct-14-2013 11:45 AM

OrthoCyte Corporation Presents at 2013 Stem Cell Meeting on the Mesa, Oct-14-2013 11:45 AM. Venue: Estancia La Jolla Hotel & Spa, La Jolla Ballroom AB, 9700 North Torrey Pines Road, La Jolla, CA 92037, United States.

OrthoCyte Corporation Presents at World Stem Cell & Regenerative Medicine Congress, May-21-2013 04:55 PM

OrthoCyte Corporation Presents at World Stem Cell & Regenerative Medicine Congress, May-21-2013 04:55 PM. Venue: Victoria Plaza, London, United Kingdom. Speakers: Francois Binette, Vice President of Research and Business Development.

OrthoCyte Corporation Appoints Francois Binette as Vice President of Research and Business Development

BioTime Inc. and OrthoCyte Corporation announced the appointment of Francois Binette, PhD, as OrthoCyte's Vice President of Research and Business Development. Dr. Binette's primary focus will be to develop and partner near- and long-term product opportunities in regenerative medicine with an emphasis on orthopedic diseases and injuries. OrthoCyte is a wholly owned subsidiary of BioTime Inc. that develops cellular therapeutics for orthopedic repair, diseases, and injuries. Dr. Binette most recently was the founder of Rediens Inc. Prior to establishing Rediens, he was Director of Biologics R&D for the Spinal & Biologics business unit of Medtronic Inc., and he also served in a variety of positions with Johnson & Johnson. He is currently a fellow with the International Cartilage Repair Society.

Similar Private Companies By Industry

Company Name Region
Celcuity, LLC United States
AVM Licensing Corp. United States
Calretex, LLC United States
ApoTech, LLC United States
Kineta Prime Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OrthoCyte Corporation, please visit www.orthocytecorp.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.